Latest Quarterly Sales News

Vault Minerals delivered a strong September quarter with record gold production and advancing key infrastructure upgrades, setting the stage for significant free cash flow growth in FY27.

Freelancer Limited reported a steady third quarter with operational profitability and notable growth in AI-related projects and Loadshift revenues, despite a year-on-year dip in overall marketplace volume.

CONNEQT Health reports robust sales momentum for its CONNEQT Pulse arterial health monitor, with quarterly sales growth exceeding 50% and a fresh order for 10,000 units to meet rising demand.

Genetic Signatures Ltd reports a robust start to FY2026 with a 20% quarterly sales increase, driven by new US contracts and strong growth in EMEA and Australia. The company also bolsters its leadership with a new CTO appointment.

Connexion Mobility reported a modest 1% revenue increase to $2.9 million in Q1 FY26, while net profit before tax declined 19% due to the absence of prior quarter government incentives. The company is advancing its SaaS platform footprint in US automotive retail and investing strategically in Covertrue Group.

Aroa Biosurgery delivered a robust September quarter with strong cash flow and record sales of its Myriad product, while reaffirming its FY26 revenue and EBITDA guidance. The company also highlighted a promising US Medicare reimbursement proposal for its Symphony product.

Challenger Limited reported a solid 4% increase in total Life sales to $2.5 billion in Q1 FY26, buoyed by strong annuity sales and strategic partnerships. The company reaffirmed its FY26 earnings guidance while highlighting upcoming regulatory changes expected to benefit the sector.

MyEco Group reported a modest 2% rise in Q1 FY26 sales, driven by a doubling in council and waste channel revenues despite ongoing headwinds from U.S. tariff changes impacting white label sales.

Summerset Group has achieved its highest-ever quarterly sales of occupation rights, driven by strong demand for care-related living options and steady growth beyond major cities.

Biome Australia Limited has reported a record-breaking $5.94 million in sales revenue for Q1 FY26, surpassing forecasts and accelerating toward its ambitious Vision 27 revenue goals.

Orthocell has appointed its first Canadian distributor for Remplir, its innovative nerve repair device, ahead of an official launch at a major surgical conference in Vancouver. The move marks a significant step in expanding the product’s international footprint.

Biome Australia Limited projects its Q1 FY26 sales revenue to exceed $5.5 million, breaking its previous quarterly record and signaling continued momentum in the microbiome health sector.